SGLT2 Inhibitors – Beyond Glycaemic Control
March 12 @ 12:45 pm – 2:00 pm
Beyond HbA1c: Modern Diabetes Care in Primary Care Nursing
The first in a series of three one-hour Lunch & Learn sessions designed for nurses working in general practice, focusing on contemporary diabetes care beyond glycaemic control.
Session 1 SGLT2 Inhibitors: Beyond Glycaemic Control
Session overview/content:
This session explores the role of SGLT2 inhibitors in modern diabetes care, with a particular
focus on their cardiovascular and renal benefits. It will move beyond glucose lowering to help
nurses understand why these medications are increasingly used in people with type 2 diabetes
who have, or are at risk of, heart failure and chronic kidney disease. Practical nursing
considerations, monitoring, and patient conversations will be highlighted throughout.
Aim:
To enable primary care nurses to understand the non-glycaemic benefits of SGLT2 inhibitors
and their role in improving cardiovascular and renal outcomes in people with type 2 diabetes.
Learning objectives:
- Understand key nursing considerations, including side effects, sick day rules, and
- patient counselling
- By the end of this session, participants will be able to:
- Describe how SGLT2 inhibitors work beyond glucose lowering
- Explain the cardiovascular benefits of SGLT2 inhibitors, particularly in heart failure
- Recognise the renal protective effects of SGLT2 inhibitors in people with type 2
- diabetes
- Identify which patients in primary care are most likely to benefit from SGLT2 inhibitor
- therapy
Speaker: Tracy Kirk – Director of Education at the Primary Care Respiratory Training Centre.
